From dry eye to GLP-1s, this year's conference brought a variety of insights from key experts in optometry. Want more ...
Gromacki said that, at the time of the discussion, there were no FDA-approved drug-eluting lenses in the US. She mentioned ...
Patient quality of life has been shown to be severely impaired by the associated ocular surface symptoms, so treatment aims for symptomatic relief and prevention of further damage to the ocular ...
Walline, American Academy of Optometry president, shares this year's conference attendance numbers, clinical pearls, and what ...
Thomas Wong, OD, FAAO, details a session he presented alongside Ronald Gentile, MD, FACS, FASRS, at AAOpt 2026. Thomas Wong, ...
The Nobel Assembly at Karolinska Institutet announced that the 2026 Nobel Prize in Physiology or Medicine will be shared ...
Enspryng is the first subcutaneous, at-home treatment option for TED and the first interleukin (IL)-6 receptor inhibitor approved in the indication. The FDA has approved Enspryng (satralizumab, ...
The approval gives eye care providers a new pharmacologic option for adults with presbyopia. Phentolamine is a non-selective alpha-1 and alpha-2 adrenergic antagonist, and the drug reduces pupil ...
The US FDA Dermatologic and Ophthalmic Drugs Advisory Committee will meet October 30, 2026, to review new drug application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results